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Abstract The Ts65Dn mouse is trisomic for orthologs of
about half the genes on Hsa21. A number of phenotypes in
these trisomic mice parallel those in humans with trisomy
21 (Down syndrome), including cognitive deﬁcits due to
hippocampal malfunction that are sufﬁciently similar to
human that ‘‘therapies’’ developed in Ts65Dn mice are
making their way to human clinical trials. However, the
impact of the model is limited by availability. Ts65Dn
cannot be completely inbred and males are generally
considered to be sterile. Females have few, small litters and
they exhibit poor care of offspring, frequently abandoning
entire litters. Here we report identiﬁcation and selective
breeding of rare fertile males from two working colonies of
Ts65Dn mice. Trisomic offspring can be propagated by
natural matings or by in vitro fertilization (IVF) to produce
large cohorts of closely related siblings. The use of a robust
euploid strain as recipients of fertilized embryos in IVF or
as the female in natural matings greatly improves hus-
bandry. Extra zygotes cultured to the blastocyst stage were
used to create trisomic and euploid embryonic stem (ES)
cells from littermates. We developed parameters for cryo-
preserving sperm from Ts65Dn males and used it to pro-
duce trisomic offspring by IVF. Use of cryopreserved
sperm provides additional ﬂexibility in the choice of oocyte
donors from different genetic backgrounds, facilitating
rapid production of complex crosses. This approach greatly
increases the power of this important trisomic model to
interrogate modifying effects of trisomic or disomic genes
that contribute to trisomic phenotypes.
Introduction
The discovery by LeJeune et al. (1959) that individuals
with Down syndrome (DS) inherit three copies of the G
group chromosome now known as chromosome 21 (Hsa21)
established the basis for subsequent research in this area.
The advent of molecular biology and of human gene
mapping provided information about the genes on Hsa21 at
the time when developments in mouse embryology (i.e.,
transgenic mice) provided the opportunity to examine gene
dosage effects on all aspects of mammalian function. By
localizing the positions of genes across different mamma-
lian genomes, comparative mapping identiﬁed genes from
Hsa21 on mouse chromosomes (Mmu) 16, 17, and 10
(Reeves et al. 2001).
Gene mapping led to the production of transgenic mice
with extra copies of individual genes mapped to Hsa21 or
homologous regions of the mouse genome (Groner 1995).
Early on, however, it was not clear that gene dosage would
have effects in mice analogous to those in human beings.
Early work in mice with trisomy for all of Mmu16 initiated
thinking in this direction (Gropp et al. 1975); but while this
model inspired further developments in the ﬁeld, the Ts16
mouse does not represent a genetic model of trisomy 21
and is no longer utilized as such.
However, the fundamental question of the existence of
‘‘mouse Down syndrome’’ became addressable by the
transformative experiments of Muriel Davisson beginning
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produced aneuploid mice carrying additional large seg-
ments of chromosomes resulting from induced transloca-
tions (Davisson et al. 1990). The chromosomes involved
were deﬁned by G-banding and those that involved distal
Mmu16 were assessed using somatic cell genetic approa-
ches to map breakpoints precisely (Davisson et al. 1993).
Hundreds of interesting translocations were produced, but
the ‘‘crown jewel’’ of these was unquestionably the
Ts65Dn mouse, in which a reciprocal translocation
between the distal end of Mmu16 and the pericentromeric
region of Mmu17 resulted in a small marker chromosome,
T65Dn. This marker can segregate onto an otherwise nor-
mal karyotype as an extra chromosome, producing Ts65Dn
mice which have 41 chromosomes (and 41 centromeres)
resulting in trisomy for more than 100 genes that are found
on Hsa21. This mouse made it possible to ask whether a
trisomic mouse has phenotypes corresponding to those in
DS, the answer to which was a resounding afﬁrmative
(Reeves et al. 1995).
This initial characterization of Ts65Dn included the ﬁrst
demonstration of hippocampal-based deﬁcits in this model,
a ﬁnding quickly conﬁrmed by other prominent investiga-
tors around the world (Coussons-Read and Crnic 1996;
Escorihuela et al. 1995; Holtzman et al. 1996). Indeed, this
speciﬁc ﬁnding inspired the development of tests for hip-
pocampal function in children with DS (Pennington et al.
2003). Ts65Dn has become the standard model for DS
research, providing insights into diverse aspects of DS
phenotypes, including brain development and function,
development of neural crest-derived structures including
the skeleton of the face and mandible, and resistance to
cancer in people with DS to name just a few (Moore and
Roper 2007). The model is sufﬁciently robust that it has
recently been used to discover potential therapeutic
approaches to amelioration of cognitive deﬁcits speciﬁc to
DS (Reeves and Garner 2007; Salehi et al. 2007).
Like all models, Ts65Dn does not perfectly reﬂect the
human condition. First, orthologs of only about half of the
genes from Hsa21 are trisomic in these mice and a number
of genes from Mmu17 that are not orthologous to Hsa21
are present in the T65Dn marker chromosome (Gardiner
et al. 2003). These trisomic mice cannot be fully inbred and
so Ts65Dn is maintained as an advanced intercross
between the C57BL/6 (B6) and C3H strains. From a
practical standpoint, the model is limited by very difﬁcult
husbandry. Males are generally sterile so that the line has
been propagated only through females since its develop-
ment. As with all mice, litters are variable in size, but
Ts65Dn have smaller litters than euploid, and while the
frequency of the extra chromosome is Mendelian at
midgestation, perinatal attrition occurs so that litters
include only about 25–35% trisomic pups at weaning
(Roper et al. 2006; Williams et al. 2008). Ts65Dn females
are poor mothers and approximately 40% of litters are
abandoned or otherwise produce no survivors (Moore
2006; Williams et al. 2008). Thus, it is often not possible to
generate sufﬁcient siblings to carry out experiments in the
most closely related, age-matched mice. These issues make
it necessary to maintain large colonies to produce sufﬁcient
mice, make it difﬁcult to breed multiple mutations (or even
one) onto the trisomic background, limit procedures
requiring induced ovulation, e.g., for the production of
embryos from which to develop embryonic stem (ES) cells,
and pose an overall practical limit to applications for the
model.
Methods
Mice
Female B6EiC3Sn-a/A-Ts(17
16)65Dn mice (herein
Ts65Dn) were obtained from the Jackson Laboratory
(JAX) (http://jaxmice.jax.org/strain/001924.html) and
maintained by crossing females to male (C57BL/
6J 9 C3H/HeJ)F1 mice (B6C3). In some cases, male
B6EiC3Sn-a/A were used as fathers. Trisomic mice and ES
cell lines were identiﬁed by qualitative PCR and ﬂuores-
cence in situ hybridization (FISH) (Lorenzi et al. 2010;
Moore et al. 1999). Institute of Cancer Research (ICR)
strain mice were obtained from Taconic Farms, Inc. Mice
for these experiments were generated and housed at
Franklin and Marshall College (F&M) or at Johns Hopkins
School of Medicine (JHU). All procedures were approved
by Institutional Animal Care and Use Committees.
Male offspring were singly housed with females upon
weaning and fertile males were identiﬁed by production of
litters. Male Ts65Dn mice produced from trisomic females,
from trisomic males by IVF, or from trisomic males by
natural mating were screened for fertility for 3 or more
months. Fertile trisomic mice of both sexes were incor-
porated into our breeding colonies.
Cryopreservation of sperm
Several protocols were attempted and the highest-efﬁ-
ciency preservation of Ts65Dn sperm was accomplished
using the JAX cryopreservation service protocol which is
based on that of Ostermeier et al. (2008). Sperm concen-
tration was increased with trisomic males compared to the
amounts for euploid mice as described below. Brieﬂy,
sperm was recovered from one or two males, as described
below, in cryoprotective medium, 18% rafﬁnose (w/v)
(Sigma R7630), 3% skim milk (w/v) (BD Diagnostics
232100), and 477 mM monothioglycerol (Sigma M6145)
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gently to equilibrate distribution. Sperm was stored in
French straws (IMV AAA201) and placed in liquid nitro-
gen vapor phase for 10 min in a cooling device sufﬁcient to
achieve a cooling rate of approximately 37C/min. After
10 min, straws were plunged into liquid nitrogen for
storage.
In vitro fertilization
Superovulation of female donor mice was accomplished by
giving 5 IU Pregnant Mare Serum Gonadotropin (PMS,
CalBiochem #367222) via intraperitoneal (IP) injection
about 60 h prior to the IVF. This was followed about 48 h
later by IP injection of 5 IU Human Chorionic Gonado-
tropin (HCG, CalBiochem #230734). Sperm preparation
was modiﬁed from standard protocols to optimize condi-
tions for Ts65Dn donors. Fertilization dishes were prepared
with four to ﬁve drops (250 ll) of Research Vitro Fert
(RVF, K-RVFE-50 Cook Medical) on 60-mm culture
dishes (per dish—1 drop per 4 females). Drops were cov-
ered with embryo-tested mineral oil and placed in a 5%
CO2 incubator to equilibrate (C20 min). Culture dishes
were prepared by placing 50-ll drops of RVF on 60-mm
culture dishes and covered with embryo-tested mineral oil.
Plates were placed in a 5% CO2 incubator until needed.
Fresh sperm was collected 12 h after females were primed
by HCG injection. The donor male was euthanized and the
caudal epididymides and vas deferens were removed and
placed in a 35-mm culture dish containing 1 ml RVF per
male. Using a 28-g insulin syringe and a pair of ﬁne for-
ceps, six cuts were made in the epididymides. The vas
deferens was progressively squeezed with syringe and
forceps to express the sperm. The dish with sperm was
placed on a 37C slide warmer for 10 min to allow the
sperm to swim out. Ten-microliter aliquots of sperm were
transferred to each drop of the fertilization dish and cul-
tured in a 5% CO2 incubator. After fertilization, dishes
were returned to the incubator and two-cell embryos were
transferred to recipient mothers the following day. Intro-
duction of two-cell embryos to prepared recipients was
carried out using standard procedures as described (Hogan
et al. 1994).
Development of ES cells
Following IVF and progression to the two-cell stage,
embryos that were not transferred to pseudopregnant
mothers were cultured in a 5% CO2 incubator for 3 or more
days in 50-ll drops of M16 embryo culture medium
(Millipore MR-010-D) under embryo-tested mineral oil.
Blastocysts were removed and cultured on gelatin-coated
4-well dishes without feeder cells for 4–5 days in ES media
which is high-glucose DMEM, 15% fetal calf serum, 19
MEM nonessential amino acids (Invitrogen), 2 mM gluta-
mine (Invitrogen), 100 mM b-mercaptoethanol (Sigma)
containing 0.5 unit/ml ESGRO (Millipore) and 36 lM
PD98059 (Sigma). PD98059 was used only during the
initial 4–5 days of culture. Outgrowths of each inner cell
mass were isolated and trypsinized in 20-ll drops of 0.25%
trypsin under oil at 37
o C for 10 min and then dispersed
with a ﬁnely drawn glass pipette and transferred to a well
of a 96-well plate containing mitomycin C-treated mouse
embryonic ﬁbroblast feeder cells and ES media. ES cell
colonies appeared in 2–5 days. They were isolated based
on morphology, plated on ﬁbroblast feeder cell layers, and
expanded in ES media containing 0.5 unit/ml ESGRO.
Results
Rare Ts65Dn males are fertile
When ﬁrst characterized, Ts65Dn males were believed to
be infertile (Davisson et al. 1993) as are males who have
Down syndrome. While there are anecdotal reports of
fertile Ts65Dn males, the frequency is low and has not
been established precisely. It is not unexpected that males
with an extra centromere, as occurs due to the presence of
the T65Dn marker chromosome, would be infertile; how-
ever, at least some of the reduced fertility is apparently due
to the trisomic genes involved. A version of Ts65Dn exists
in which the small marker chromosome is involved in a
Robertsonian translocation to Mmu12. This mouse, called
Ts[Rb(12.17
16)]2Cje, has the same gene dosage imbalance
as Ts65Dn but a normal number of centromeres (Villar
et al. 2005). The original report indicated that males were
fertile but that only 1–5% of their progeny were trisomic.
Different frequencies for transmission of both Ts2Cje and
Ts65Dn have been observed in different colonies, but
greatly reduced male transmission of extra genetic material
is a characteristic of both strains (RR and CM, unpublished
observations).
In the course of aging mice for various studies, young
males were housed with females from about the time of
weaning, with occasional litters resulting (in CM’s colony).
Several males were identiﬁed that fathered multiple litters,
transmitting the T65Dn marker chromosome to a subset of
progeny. Over the course of 4 years, we produced a total of
453 progeny from natural matings of fertile Ts65Dn males,
including similar numbers of males and females (Table 1).
Litter sizes at weaning were similar, with Ts65Dn males
producing 5.4 pups per litter (54 litters total) and Ts65Dn
females producing on average 4.9 pups per litter (140 lit-
ters) (p = 0.136). However, about two of every ﬁve litters
born to Ts65Dn females is abandoned or killed, while we
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Of the litters from trisomic males, 28% of offspring were
trisomic at weaning, as expected for Ts65Dn progeny
(Moore 2006; Roper et al. 2006).
Sperm from fertile Ts65Dn males is effective for IVF
In addition to male infertility, generation of Ts65Dn mice
is hampered by husbandry concerns. IVF offers the possi-
bility of using euploid surrogate mothers with good hus-
bandry characteristics. Standard procedures were used to
prepare sperm from Ts65Dn males and, in general, fewer
motile sperm were evident. Several different dilutions were
used for the initial IVF procedure. Optimal results were
obtained when sperm were recovered from two epididy-
mides/vas deferens placed in 1 ml of human tubal ﬂuid
(HTF) medium, which was then diluted further to a con-
centration two to three times higher than is standard for
euploid strains for fertilization, i.e., 10–15 ll per 250 llo f
HTF medium instead of the 5 ll that would be used from
euploid males. The yield is variable based on concentration
and volume of sperm obtained, but in general six to ten
straws are obtained. Each can be used for IVF in which the
number of progeny is limited primarily by the number of
oocytes obtained and the number of surrogate mothers into
which they are transferred.
Oocytes were prepared from superovulated B6C3
females and incubated with prepared sperm for 4 h,
washed, and incubated overnight using standard procedures
(see Methods). Two-cell embryos were transferred to
pseudopregnant ICR females, which bear large litters and
provide excellent husbandry. In three separate rounds of
IVF using fresh sperm and 30–40 B6C3F1 oocyte donors
per round, a total of 53 embryo transfers where performed.
Thirty-eight litters were identiﬁed resulting in 271 pups
(7.1 pups per litter on average) (Table 1). There were no
recorded losses of whole litters. Although we have not
sought to recover the maximum possible number of pups
(by maximizing the number of superovulated females), one
round of IVF resulted in 153 pups. There was no signiﬁcant
sex bias (55% male) and 31% were trisomic at weaning as
expected from natural matings of Ts65Dn (Roper et al.
2006; Williams et al. 2008).
Sperm freezing allows further ﬂexibility for IVF
Cryopreservation of sperm is an important colony man-
agement tool and also provides experimental ﬂexibility,
e.g., for rapid expansion of colonies. We ﬁrst used a con-
ventional cryopreservation procedure that has proven
effective for a number of mixed genetic backgrounds to
freeze Ts65Dn sperm (Sztein et al. 1997). However, few
motile sperm were recovered after thawing and no two-cell
embryos were produced. It has long been known that the
success rates for recovery of frozen sperm are strain
dependent. Historically, B6 has provided poor recovery of
frozen sperm, but several procedures have recently repor-
ted success with this strain (Ostermeier et al. 2008). JAX
has developed a robust procedure for cryopreservation of
sperm from a number of strain backgrounds and this
technique proved to be efﬁcacious to cryopreserve and
recover Ts65Dn sperm.
As we recovered fewer motile sperm from Ts65Dn, we
modiﬁed the protocol to provide a threefold increase in
concentration for cryopreservation. In the two-cell test,
80% of B6C3 oocytes fertilized with sperm that had been
frozen progressed to the two-cell stage. We performed a
small test IVF with an aliquot of cryopreserved sperm to
produce three litters, including three male and three female
trisomic Ts65Dn mice. This was a single small proof-of-
concept experiment, but scale-up is readily accomplished
simply by superovulating more females to produce addi-
tional oocytes and transferring to more recipient mothers.
The ability to cryopreserve sperm further expands ﬂexi-
bility for genetic experiments.
Embryonic stem cells from Ts65Dn mice
Availability of ES cells for Ts65Dn has been a community
goal for several years. Attempts to create Ts65Dn ES cells
by a conventional route, i.e., timed pregnancy of supe-
rovulated Ts65Dn females with recovery of blastocysts that
can then be propagated in culture, have proven to be
problematic. Superovulation works poorly in this strain so
there is a very low production of embryos. Sacriﬁce of a
large number of Ts65Dn females is problematic as these
represent the breeding stock for the colony. With the pro-
duction of hundreds of embryos by IVF, a large number of
blastocysts could be recovered for production of ES cells.
Ten ES lines were recovered and karyotyped. All had a
normal chromosome complement plus or minus the T65Dn
marker chromosome. Two of the ten lines that we
Table 1 Characteristics of offspring from natural mating and IVF
with male Ts65Dn
No. of Ts65Dn No. of euploid % male % trisomic
Natural
Female 59 175 48.3 28.3
Male 69 150
Total 128 325
IVF
Female 35 87 55.0 31.0
Male 49 100
Total 84 187
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(Fig. 1).
Ts65Dn mice generated from males are similar to those
from females
Since Ts65Dn mice are typically produced from a trisomic
mother, both maternal and embryonic components of the
placenta are trisomic in trisomic pups, while their euploid
siblings have a trisomic maternal component but a euploid
embryonic component. This may contribute to the fact that
Ts65Dn mice are smaller than their euploid littermates at
birth and throughout life (Moore 2006; Roper et al. 2006).
When the T65Dn chromosome is transmitted by the father,
the mother’s contribution is always euploid.
All animals produced here were used in experiments
examining various effects of ploidy as opposed to provid-
ing a comprehensive set of growth data for IVF versus
natural mating. However, we selected a cohort of animals
produced by IVF that were sacriﬁced between 3 and
4 months of age and compared their weights to those of
trisomic mice from natural mating of trisomic mothers.
Weights for Ts65Dn mice 3–4 months old that were born
to trisomic mothers compared to the weights of those
produced by IVF were lower, but not signiﬁcantly so (28.4
vs. 30.4 g, p = 0.2, n = 31 male Ts65Dn born from
mothers, 10 males from IVF). Some Ts65Dn mice gener-
ated from IVF were used in experiments with behavioral
endpoints. Their impairment in performance in the Y-maze
and the Morris water maze was the same as we and others
have previously reported for Ts65Dn mice from trisomic
mothers (data not shown).
Heritability of male fertility in trisomic mice?
Exact frequencies of the incidence of Ts65Dn male fertility
from founder stocks at JAX are not available, although this
frequency was long held to be 5% or less. The initial
ﬁnding of fertile Ts65Dn males was serendipitous and the
time of exposure to females was variable depending on the
use of these mice in other experimental procedures. Fur-
thermore, the percentage of males in our working colonies
that were produced by IVF or who have a relative produced
by IVF has increased as more procedures are successful
and trisomic progeny, male and female, are incorporated
into breeding procedures. We now identify fertile males
with much higher frequency than when the process started
at F&M (Table 2), but the possibility that improved
screening contributes to this cannot be ruled out.
All but one of the fertile trisomic males that we have
observed can be traced by euploid or trisomic lineage to a
single founder Ts65Dn female introduced into the F&M
colony from JAX in 2005. However, the T65Dn chromo-
some in a given fertile trisomic male can be traced to one
of ﬁve different Ts65Dn females (crossed to euploid males
who had a fertile trisomic male relative). We do not know
the relationships of these Ts65Dn females, but they were
shipped to F&M or to JHU at different times over 5 years
and are presumably only distantly related. At any rate, it
appears unlikely that a variant of the T65Dn marker
chromosome is primarily responsible for male fertility.
Discussion
Ts65Dn has become the standard model for Down syn-
drome work but remains limiting for practical reasons
related to cost, husbandry, and the expertise required to
grow and type these mice. We established a useful
approach to overcome the most important logistical limi-
tations of Ts65Dn. Using fresh or cryopreserved sperm
from fertile males, we generated large cohorts of siblings
Fig. 1 Trisomic ES cells were established from Ts65Dn blastocysts
resulting from IVF. a ES cell colonies from line Ts65.ES1 on
background feeders. b A metaphase spread of the Ts65.ES1 line; the
expected 40 chromosomes plus the encircled T65Dn marker
chromosome are visible. c Interphase FISH (Moore et al. 1999)
shows three signals in the Ts65.ES1 cell line. For the cell at the lower
right, the third signal is beneath the plane of focus in this image
Table 2 Frequency of Ts65Dn male fertility
Fertile males Tested males % fertile males
JHU 23 55 41.8
F&M 20 88 22.7
Total 43 143 30.1
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husbandry, assuring that more mice survive to weaning.
While we used B6C3 F1 females as oocyte donors here,
inbred lines, such as B6, can also provide large numbers of
oocytes from superovulation. Progeny from such IVF
procedures with Ts65Dn would be on average 75% B6 and
25% C3H; since they are full sibs, half of the remaining
variable portion of the genomes (25%) would be identical
by descent (ibd), i.e., any pair of mice from this scenario
would share on average 87.5% of their genetic information,
without even accounting for the portions of the B6 and
C3H genomes that are already ibd. It can be argued that
many phenotypes that are detectable only with less than
this small amount of genetic variability are of minimal
relevance to natural outbred populations, i.e., people with
trisomy 21.
Large cohorts of closely related siblings are useful for a
variety of experiments, especially behavioral testing or
outcomes with seasonal variation where it would be very
difﬁcult to generate sufﬁcient offspring by conventional
matings with Ts65Dn females in a short period of time. In
another example, establishment of ES cells for Ts65Dn has
been problematic due to low levels of superovulation and
hence small numbers of blastocysts recovered from triso-
mic females. We obtained multiple trisomic ES lines using
excess blastocysts from IVF. Finally, the ability to do
complex crosses with multiple mutant alleles carried in
the superovulated females is greatly enhanced by this
approach.
Increasingly, contributions of individual genes to
Ts65Dn phenotypes are being assessed by breeding null
alleles or segmental deletions onto the trisomic background
(e.g., Olson et al. 2004, 2007; Salehi et al. 2006; Sussan
et al. 2008). Matings produce the desired genetic combi-
nations 25% of the time for one gene; this frequency is
further reduced to about 15–20% by the sub-Mendelian
recovery of Ts65Dn at weaning. In a conventional breeding
colony, only males are used for experiments since all
females need to be put into production to generate exper-
imental animals; thus, 10% of weanlings might be suitable
for this experiment. A three-way cross to combine alleles
of two genes on the Ts65Dn background would be
expected to produce the desired genotype in 5% of weaned
progeny. These frequencies assume no deleterious inter-
action of trisomy with the modiﬁed genes, which is fre-
quently not the expected outcome.
Thus, months can be required to produce sufﬁcient
animals to support analysis. Doing IVF with fresh sperm
requires that a large number of female mice between 3 and
4 weeks of age be available near the time when the male is
identiﬁed as fertile, since fertile trisomic males become
sterile much younger than their euploid counterparts. To do
this would require an enormous standing breeding colony.
While production of 30 doubly mutant females 3–4 weeks
of age remains a considerable task, this step is no longer
limited to a short window of male fertility since frozen
sperm can be used. In our largest IVF, we recovered more
than 450 oocytes from superovulated females, resulting in
more than 300 two-cell embryos the next day.
We observed a far higher than expected frequency of
male fertility from male Ts65Dn with a fertile male
ancestor. These observations raise the possibility that QTL
associated with this trait could be mapped in mice from
these pedigrees. In practical terms, the use of fertile
Ts65Dn males or cryopreserved sperm for generation of
trisomic mice allows us to rapidly produce large cohorts of
closely related trisomic mice for complex genetic analysis
of the effects of trisomy on development and function.
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